DGAP-News: H&R AG confirms good preliminary Q1 figures

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
DGAP-News: H&R AG confirms good preliminary Q1 figures

DGAP-News: H&R AG / Key word(s): Quarter Results/Interim Report H&R AG confirms good preliminary Q1 figures 15.05.2015 / 09:28 --------------------------------------------------------------------- Press release H&R AG confirms good preliminary Q1 figures - EBITDA doubled - Significant growth reported in refining segment - All three segments report positive ongoing results Salzbergen (Germany), May 15 2015. H&R AG has confirmed its preliminary sales and profit figures for the first part of 2015: In the first quarter the company achieved, with sales of EUR 263.0 million (6.9% lower than in the same quarter of the year before; Q1-2014: EUR 282.6 million), a doubling of earnings before interest, taxes, depreciation and amortization (EBITDA) to EUR 15.5 million in total (equivalent period of the previous year: EUR 7.7 million). The quarter just finished also made positive contributions to results at all levels. Overview of the main figures: <pre> in EUR million Q1-2015 Q1-2014* Change Sales revenues 263.0 282.6 -19.6 Operating income/loss (EBITDA) 15.5 7.7 7.8 EBIT 8.1 2.1 6.0 Earnings/loss before taxes 5.0 -1.6 6.6 Consolidated earnings after 4.8 -1.1 5.9 minority interests Consolidated earnings per share (EUR)* 0.13 -0.04 0.17 Operating cash flow -3.0 -29.6 26.6 Free cash flow -8.8 -32.5 23.7 31.3.2015 31.12.20 Change 14 Total assets 704.5 706.6 -2.1 Shareholders' equity 267.0 248.9 18.1 Equity ratio (%) 37.9 35.2 2.7 </pre> * A comparison of earnings per share before / after the increase in capital through a contribution-in-kind is only possible to a limited extent, given the different numbers of shares involved. The segment represented by ChemPharm Refining made an important contribution to these improved results, despite a raw-material cost related 23.3% drop in sales of EUR 168.2 million (Q1 2014: EUR 219.3 million) with an EBITDA of EUR 9.8 million (Q1 2014: EUR 5.5 million). International activities - the segment ChemPharm Sales - are presented this year, thanks to the contribution of China in autumn 2014, with a figure of EUR 82.1 million, which is 54% better in terms of sales (Q1 2014: EUR 53.3 million) and which likewise achieves, with an EBITDA of EUR 6.1 million (Q1 2014: EUR 3.4 million), significantly better operating income. The plastics segment managed to achieve a growth of 8.5% in sales, to EUR 15.3 million (Q1 2014: EUR 14.1 million), while notching up, in contrast to the same quarter of the previous year (Q1 2014; EUR -0.6 million), a positive EBITDA of EUR 0.3 million. Given these good quarterly results, H&R Aktiengesellschaft expects the current trend to continue, and confirms its forecast for 2015. Working on the assumption of a stable oil price, H&R AG likewise continues to count on an EBITDA that is likely to fluctuate between EUR 45 million and EUR 65 million. For detailed statements regarding H&R AG's commercial development and earnings, the company refers to the report for the first quarter of 2015, which has been published today and has been made available for download from www.hur.com. Contact: H&R AG, Investor Relations / Kommunikation, Ties Kaiser Neuenkirchener Straße 8, 48499 Salzbergen Tel.: +49 40 43218-321, Fax: +49 40 43218-390 Mail: ties.Kaiser@hur.com www.hur.com H&R AG: H&R AG is a specialty-chemicals company listed on the Frankfurt Stock Exchange's Prime Standard segment. It develops and manufactures crude-oil-based chemical and pharmaceutical specialty products and produces high-precision plastic parts. Forward-looking statements and forecasts: This press release contains forward-looking statements. The statements are based on the current estimates and forecasts by the Executive Board and the information available to the Board at this time. These forward-looking statements should not be interpreted as a guarantee that the projected future developments and results contained therein will materialize. The future developments and results are dependent on a number of factors that entail various risks and contingencies and are based on assumptions which could prove to be incorrect. We do not assume any responsibility for updating the forward-looking statements contained in this press release. --------------------------------------------------------------------- 15.05.2015 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: H&R AG Neuenkirchener Str. 8 48499 Salzbergen Germany Phone: +49 (0)40 43 218 321 Fax: +49 (0)40 43 218 390 E-mail: investor.relations@hur.com Internet: www.hur.com ISIN: DE0007757007 WKN: 775700 Listed: Regulated Market in Dusseldorf, Frankfurt (Prime Standard), Hamburg; Regulated Unofficial Market in Berlin, Hanover, Munich, Stuttgart End of News DGAP News-Service --------------------------------------------------------------------- 357777 15.05.2015

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Insider Risk Makes Human Judgment a Security Priority

Updated Category News Views 114

A badge, a password, and a locked gate can all look reassuring right up until the person holding them starts to crack. Signpost Six's new report, The Psychology of Insider Risk, lands on an uncomfortable truth: the most consequential security weakness may not be a system at all. It may be an employee under strain, in conflict, in debt, making a mistake, or being quietly...

Continue Reading
Onward Therapeutics Secures $28M to Bolster Oncology R&D

Updated Category News Views 99

Cashing In to Conquer Cancer In the risk-laden world of biotech, Onward Therapeutics has just bagged a hefty NT$900 million—roughly US$28 million—from its Series B financing. That's not pocket change and speaks to the level of confidence their backers have, even as they plant their global headquarters firmly in Taipei since relocating from Switzerland. A Deep Dive...

Continue Reading
Veterans United Foundation Marks 15 Years of Giving

Updated Category News Views 0

A Milestone Measured in More Than Checks Fifteen years can turn a workplace charity into background noise, but this one plainly has not drifted into autopilot. Veterans United Foundation closed its 2026 anniversary campaign, called The Good Goes On, with $1.5 million directed to charitable organizations, 1,145 employee volunteers, and 2,680 hours of hands-on work. That is...

Continue Reading
Polsen Flex Deal Puts Pre-Tax Funds Behind Wearables

Updated Category News Views 52

A pile of soon-to-expire FSA cash is a peculiar sales catalyst, but Polsen Health has found one. The Amsterdam-based preventative-health wearable company is partnering with Flex to let customers pay for every Polsen watch and strap using eligible HSA or FSA funds at checkout. No reimbursement chase, no claim forms, and buyers can split the cost with another card. For a...

Continue Reading
Bona's 2027 Floorcast Finds Wood and Trust Still Win

Updated Category News Views 305

Floors are turning into a long-game purchase again Gray flooring may be limping toward the exit, but the more important signal in Bona's 2027 Floorcast is that homeowners are thinking less like bargain hunters and more like custodians of an expensive asset. That is a useful read for anybody watching the home-improvement and maintenance landscape. People do not replace a...

Continue Reading
Sola's 11-Step Push Makes Salon Ownership Less Blind

Updated Category News Views 319

A pristine studio does not pay rent by itself. That is the uncomfortable little truth sitting underneath Sola Salons’ new 11-step roadmap for beauty professionals considering salon-suite ownership. The company is telling stylists, estheticians, nail technicians, massage therapists, and other independent operators to treat the move from commission work to ownership like...

Continue Reading
Kawneer’s OptiQ Window Wins a Useful Design Signal

Updated Category News Views 24

Three Nods, One Very Practical Product Claim Windows rarely stir much excitement outside an architect’s specification binder, but Kawneer has put together a respectable run with its OptiQ Offset Fixed/Projected Series Window. On November 18, 2026, the architectural aluminum-systems maker said the product had won in the Windows and Doors category at both the 2026...

Continue Reading
Racura's AML Trial Clears Its First Crucial Hurdle

Updated Category News Views 13

One signature from Sheba does not cure leukemia, but it does move Racura Oncology from talking about EMILI to doing the hard, expensive work of enrolling patients. For a company at this stage, that distinction matters. Ethics approval for the seamless Phase 2b/3 RC220 study in relapsed or refractory acute myeloid leukemia is a real operational milestone, not the sort of...

Continue Reading
SteriLance Aims for Smoother Pricks with NanoSense Move

Updated Category News Views 92

Revamping the Lancing Game Out there in Suzhou, SteriLance Medical is steering clear of just chasing meter accuracy—do enough folks even care about glorified electronics?—they're zeroing in on the needle part of the blood glucose test, the part that pricks your finger every damn day. Yep, this new initiative is inviting blood glucose monitoring (BGM) brands to embrace...

Continue Reading
LifeVac's 7,000 Reported Saves Deserve Careful Context

Updated Category News Views 225

Veggie straws are supposed to be harmless until they are not. LifeVac says a 19-month-old girl in South Dakota became unable to breathe on November 14 after eating the snack, with a sticky piece creating a complete airway obstruction. Her father retrieved the family's LifeVac, used the pediatric mask while she was on her back, and the company says one application...

Continue Reading

Top 5 Most Recently Viewed Articles

UP Oncolytics Boosts Funding to Propel Brain Cancer Research

Updated Category News Views 171

UP Oncolytics Secures Significant Grant for Research Advancement UP Oncolytics, a pioneering biotechnology company specializing in neuro-oncology, is making headlines with its latest achievement in funding. This innovative company, a spin-out from a prominent research institution, has secured a matching grant to further its mission in developing oncolytic virus therapy...

Continue Reading
US Dollar Weakness Fuels Gold's Safe Haven Appeal Amid Trade Tensions

Updated Category News Views 269

US Dollar Weakness Benefits Gold Amid Trade Concerns The US dollar has been retreating against several major currencies, largely influenced by recent dovish comments from Fed Governor Waller. The anticipation of further developments in trade negotiations is another factor keeping investors on edge as they navigate these financial currents. Fed’s Influence on the Dollar...

Continue Reading
Tesla's Strategic Partnerships with Local Suppliers in China

Updated Category News Views 468

Tesla's Strategic Partnerships with Local Suppliers in China Tesla, Inc. (NASDAQ: TSLA) is taking significant steps to enhance its operational efficiency and local presence in the world's largest automotive market, China. Recently reported developments indicate that the iconic electric vehicle manufacturer has successfully established partnerships with over 400 local...

Continue Reading
Collect a Unique Piece of History: Trump Bobblehead Release

Updated Category News Views 324

Royal Bobbles Launches Limited Edition Bobblehead of President-Elect Trump Add an Iconic Piece of Presidential Inauguration History with a One-of-a-Kind President-Elect Donald J. Trump Bobblehead A Historic Collectible Honoring Strength and Patriotism Royal Bobbles, recognized as the original bobblehead maker, has made an exciting announcement. They are launching the 2025...

Continue Reading
Extant Capital's New $200 Million Investment Marks Growth Path

Updated Category News Views 219

Extant Capital Receives Significant Investment Boost Extant Capital, an alternative asset management firm, has made an exciting announcement regarding a substantial new investment. The firm has successfully secured a $200 million cornerstone investment from New Holland Capital, marking a pivotal moment in its growth journey. This strategic partnership is set to enhance...

Continue Reading